Literature DB >> 9479673

Eye movement desensitization and reprocessing (EDMR) treatment for combat-related posttraumatic stress disorder.

J G Carlson1, C M Chemtob, K Rusnak, N L Hedlund, M Y Muraoka.   

Abstract

Despite the clinical and social impact of posttraumatic stress disorder (PTSD), there are few controlled studies investigating its treatment. In this investigation, the effectiveness of two psychotherapeutic interventions for PTSD were compared using a randomized controlled outcome group design. Thirty five combat veterans diagnosed with combat-related PTSD were treated with either (a) 12 sessions of eye movement desensitization and reprocessing, EMDR (n = 10), (b) 12 sessions of biofeedback-assisted relaxation (n = 13), or (c) routine clinical care, serving as a control (n = 12). Compared with the other conditions, significant treatment effects in the EMDR condition were obtained at posttreatment on a number of self-report, psychometric, and standardized interview measures. Relative to the other treatment group, these effects were generally maintained at 3-month follow-up. Psychophysiological measures reflected an apparent habituation effect from pretreatment to posttreatment but were not differentially affected by treatment condition.

Entities:  

Mesh:

Year:  1998        PMID: 9479673     DOI: 10.1023/A:1024448814268

Source DB:  PubMed          Journal:  J Trauma Stress        ISSN: 0894-9867


  26 in total

Review 1.  Examining military population and trauma type as moderators of treatment outcome for first-line psychotherapies for PTSD: A meta-analysis.

Authors:  Casey L Straud; Jedidiah Siev; Stephen Messer; Alyson K Zalta
Journal:  J Anxiety Disord       Date:  2019-08-18

Review 2.  Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults.

Authors:  Jonathan I Bisson; Neil P Roberts; Martin Andrew; Rosalind Cooper; Catrin Lewis
Journal:  Cochrane Database Syst Rev       Date:  2013-12-13

Review 3.  A FLASH OF HOPE: Eye Movement Desensitization and Reprocessing (EMDR) Therapy.

Authors:  Danielle Gainer; Sarah Alam; Harris Alam; Hannah Redding
Journal:  Innov Clin Neurosci       Date:  2020-07-01

4.  The applicability of randomized controlled trials of psychosocial treatments for PTSD to a veteran population.

Authors:  Shannon Wiltsey Stirman
Journal:  J Psychiatr Pract       Date:  2008-07       Impact factor: 1.325

5.  Meta-analysis of dropout in treatments for posttraumatic stress disorder.

Authors:  Zac E Imel; Kevin Laska; Matthew Jakupcak; Tracy L Simpson
Journal:  J Consult Clin Psychol       Date:  2013-01-21

6.  Interventions for adults with a history of complex traumatic events: the INCiTE mixed-methods systematic review.

Authors:  Hollie Melton; Nick Meader; Holly Dale; Kath Wright; Julie Jones-Diette; Melanie Temple; Iram Shah; Karina Lovell; Dean McMillan; Rachel Churchill; Corrado Barbui; Simon Gilbody; Peter Coventry
Journal:  Health Technol Assess       Date:  2020-09       Impact factor: 4.014

7.  Systematic review and meta-analyses of psychosocial interventions for veterans of the military.

Authors:  Neil J Kitchiner; Neil P Roberts; David Wilcox; Jonathan I Bisson
Journal:  Eur J Psychotraumatol       Date:  2012-12-05

Review 8.  Do all psychological treatments really work the same in posttraumatic stress disorder?

Authors:  Anke Ehlers; Jonathan Bisson; David M Clark; Mark Creamer; Steven Pilling; David Richards; Paula P Schnurr; Stuart Turner; William Yule
Journal:  Clin Psychol Rev       Date:  2009-12-13

9.  Cessation of deliberate self harm following eye movement desensitisation and reprocessing: A case report.

Authors:  Derek F McLaughlin; Iain W McGowan; Michael C Paterson; Paul W Miller
Journal:  Cases J       Date:  2008-09-23

10.  Effects of eye movement desensitization and reprocessing (EMDR) on non-specific chronic back pain: a randomized controlled trial with additional exploration of the underlying mechanisms.

Authors:  Jonas Tesarz; Andreas Gerhardt; Sabine Leisner; Susanne Janke; Mechthild Hartmann; Günther H Seidler; Wolfgang Eich
Journal:  BMC Musculoskelet Disord       Date:  2013-08-30       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.